Radiopharm Theranostics (RADX) Stock Analysis & Price (Updated Oct 16, 2026, 4:00 PM ET)
Updated Oct 16, 2026, 4:00 PM ET
- Closed at $1.03, -4.63% vs the prior close of $1.08.
- Volume 106.39K shares, 1.8x its 50-day average.
- No new SEC filings since the prior session.
- No new insider buys or sales reported since the prior session.
RADX slides 4.6% to $1.03, a 52-week low, 3 down days in a row. Closed at $1.03, -4.63% vs the prior close of $1.08. Day range $0.90–$1.14, opened at $1.02.
RADX daily analysis — what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 16, 2026 — RADX slides 4.6% to $1.03, a 52-week low, 3 down days in a row
- Closed at $1.03, -4.63% vs the prior close of $1.08. Day range $0.90–$1.14, opened at $1.02.
- Volume was 106.39K shares, 1.8x its 50-day average of 59.42K.
- Price is -46.2% vs its 50-day average ($1.91) and -73.4% vs its 200-day average ($3.88).
- 52-week range $0.90–$16.25; today's close sits at 1% of that range, 93.7% below the 52-week high.
- That makes 3 straight losses.
Oct 15, 2026 — RADX slides 3.6% to $1.08, a 52-week low
- Closed at $1.08, -3.57% vs the prior close of $1.12. Day range $1.01–$1.15, opened at $1.12.
- Volume was 65.90K shares, 1.1x its 50-day average of 59.64K.
- Price is -44.6% vs its 50-day average ($1.95) and -72.3% vs its 200-day average ($3.90).
- 52-week range $1.00–$16.25; today's close sits at 1% of that range, 93.4% below the 52-week high.
Oct 14, 2026 — RADX slides 6.7% to $1.12
- Closed at $1.12, -6.67% vs the prior close of $1.20. Day range $1.11–$1.19, opened at $1.17.
- Volume was 39.20K shares, 0.6x its 50-day average of 60.50K.
- Price is -43.5% vs its 50-day average ($1.98) and -71.4% vs its 200-day average ($3.92).
- 52-week range $1.00–$16.25; today's close sits at 1% of that range, 93.1% below the 52-week high.
Oct 13, 2026 — RADX jumps 8.1% to $1.20 on 2.4x normal volume
- Closed at $1.20, +8.11% vs the prior close of $1.11. Day range $1.01–$1.33, opened at $1.07.
- Volume was 143.10K shares, 2.4x its 50-day average of 59.31K — unusually heavy trading.
- Price is -40.6% vs its 50-day average ($2.02) and -69.6% vs its 200-day average ($3.94).
- 52-week range $1.00–$16.25; today's close sits at 1% of that range, 92.6% below the 52-week high.
Oct 12, 2026 — RADX dips 1.8% to $1.11
- Closed at $1.11, -1.77% vs the prior close of $1.13. Day range $1.10–$1.33, opened at $1.10.
- Volume was 9.60K shares, 0.2x its 50-day average of 60.99K — lighter than usual.
- Price is -46.0% vs its 50-day average ($2.06) and -72.0% vs its 200-day average ($3.96).
- 52-week range $1.00–$16.25; today's close sits at 1% of that range, 93.2% below the 52-week high.
Oct 9, 2026 — RADX rises 1.8% to $1.13
- Closed at $1.13, +1.80% vs the prior close of $1.11. Day range $1.06–$1.24, opened at $1.10.
- Volume was 65.80K shares, 1.1x its 50-day average of 61.02K.
- Price is -46.1% vs its 50-day average ($2.10) and -71.6% vs its 200-day average ($3.98).
- 52-week range $1.00–$16.25; today's close sits at 1% of that range, 93.0% below the 52-week high.
Oct 8, 2026 — RADX slides 3.5% to $1.11, a 52-week low, 6 down days in a row
- Closed at $1.11, -3.48% vs the prior close of $1.15. Day range $1.06–$1.16, opened at $1.13.
- Volume was 26.70K shares, 0.4x its 50-day average of 62.16K — lighter than usual.
- Price is -48.1% vs its 50-day average ($2.14) and -72.3% vs its 200-day average ($4.01).
- 52-week range $1.00–$16.25; today's close sits at 1% of that range, 93.2% below the 52-week high.
- That makes 6 straight losses.
Oct 7, 2026 — RADX dips 2.5% to $1.15, a 52-week low, 5 down days in a row
- Closed at $1.15, -2.54% vs the prior close of $1.18. Day range $1.10–$1.19, opened at $1.18.
- Volume was 42.40K shares, 0.7x its 50-day average of 64.61K.
- Price is -47.3% vs its 50-day average ($2.18) and -71.4% vs its 200-day average ($4.03).
- 52-week range $1.00–$16.25; today's close sits at 1% of that range, 92.9% below the 52-week high.
- That makes 5 straight losses.
Oct 6, 2026 — RADX slides 7.1% to $1.18, a 52-week low, 4 down days in a row
- Closed at $1.18, -7.09% vs the prior close of $1.27. Day range $1.16–$1.28, opened at $1.28.
- Volume was 77.50K shares, 1.1x its 50-day average of 70.55K.
- Price is -46.9% vs its 50-day average ($2.22) and -70.8% vs its 200-day average ($4.05).
- 52-week range $1.00–$16.25; today's close sits at 1% of that range, 92.7% below the 52-week high.
- That makes 4 straight losses.
Oct 5, 2026 — RADX slides 10.6% to $1.27, a 52-week low, 3 down days in a row
- Closed at $1.27, -10.56% vs the prior close of $1.42. Day range $1.00–$1.40, opened at $1.39.
- Volume was 82.30K shares, 0.8x its 50-day average of 99.62K.
- Price is -44.1% vs its 50-day average ($2.27) and -68.8% vs its 200-day average ($4.07).
- 52-week range $1.00–$16.25; today's close sits at 2% of that range, 92.2% below the 52-week high.
- That makes 3 straight losses.
- SEC filings that day: 6-K.
Oct 2, 2026 — RADX slides 4.1% to $1.42, a 52-week low
- Closed at $1.42, -4.05% vs the prior close of $1.48. Day range $1.40–$1.65, opened at $1.44.
- Volume was 62.30K shares, 0.6x its 50-day average of 98.37K.
- Price is -38.8% vs its 50-day average ($2.32) and -65.3% vs its 200-day average ($4.09).
- 52-week range $1.40–$16.25; today's close sits at 0% of that range, 91.3% below the 52-week high.
RADX latest news & SEC filings
Every SEC filing by or about RADX in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Oct 14, 2026 · Form SCHEDULE 13G — Passive stake (13G)
Passive stake (13G) — an investor reported owning more than 5%
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Oct 5, 2026 · Form 6-K — Report from a foreign company (6-K)
Report from a foreign company (6-K) — news it published at home
Oct 1, 2026 · Form 6-K — Report from a foreign company (6-K)
Report from a foreign company (6-K) — news it published at home
Sep 30, 2026 · Form 20-F — Annual report from a foreign company (20-F)
Annual report from a foreign company (20-F)
Key figures from this report aren't in the SEC's structured data yet (usually appears within a day or two).
Sep 30, 2026 · Form 6-K — Report from a foreign company (6-K)
Report from a foreign company (6-K) — news it published at home
Sep 23, 2026 · Form EFFECT — EFFECT filing
EFFECT filing
Sep 23, 2026 · Form 424B3 — Prospectus / supplement for an offering or resale
Prospectus / supplement for an offering or resale
An offering document: new shares or debt may be sold, which can increase the share count (dilution) or debt load. Size and terms are in the prospectus.
Sep 22, 2026 · Form 6-K — Report from a foreign company (6-K)
Report from a foreign company (6-K) — news it published at home
Sep 14, 2026 · Form 6-K — Report from a foreign company (6-K)
Report from a foreign company (6-K) — news it published at home
Sep 14, 2026 · Form F-3 — F-3 filing
F-3 filing
An offering document: new shares or debt may be sold, which can increase the share count (dilution) or debt load. Size and terms are in the prospectus.
Sep 11, 2026 · Form 6-K — Report from a foreign company (6-K)
Report from a foreign company (6-K) — news it published at home
Sep 9, 2026 · Form 6-K — Report from a foreign company (6-K)
Report from a foreign company (6-K) — news it published at home
Sep 4, 2026 · Form SCHEDULE 13G — Passive stake (13G)
Passive stake (13G) — an investor reported owning more than 5%
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Sep 4, 2026 · Form SCHEDULE 13D — Activist-style stake (13D)
Activist-style stake (13D) — an investor reported owning more than 5%
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Aug 28, 2026 · Form 6-K — Report from a foreign company (6-K)
Report from a foreign company (6-K) — news it published at home
Things to know before you trade RADX
- How much it moves: over the last 20 sessions the average daily move was 4.60% (largest 10.6%). That is a volatile stock.
- Liquidity: about 56.10K shares (≈$57.79K) trade per day on average. Thin volume can mean wider bid/ask spreads.
- 52-week position: $1.03 vs a range of $0.90–$16.25 (1% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: none in the last 2 years.
- Insider trades (Form 4, last 12 months, recent 25 shown): 0 open-market buys, 0 sales.
- Latest filings: 6-K Oct 5, 2026; 6-K Oct 1, 2026; 20-F Sep 30, 2026.
- Listing: Nasdaq · industry: Pharmaceutical Preparations.
RADX market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 16, 2026 | 1.02 | 1.14 | 0.90 | 1.03 | 106.39K |
| Oct 15, 2026 | 1.12 | 1.15 | 1.01 | 1.08 | 65.90K |
| Oct 14, 2026 | 1.17 | 1.19 | 1.11 | 1.12 | 39.20K |
| Oct 13, 2026 | 1.07 | 1.33 | 1.01 | 1.20 | 143.10K |
| Oct 12, 2026 | 1.10 | 1.33 | 1.10 | 1.11 | 9.60K |
| Oct 9, 2026 | 1.10 | 1.24 | 1.06 | 1.13 | 65.80K |
| Oct 8, 2026 | 1.13 | 1.16 | 1.06 | 1.11 | 26.70K |
| Oct 7, 2026 | 1.18 | 1.19 | 1.10 | 1.15 | 42.40K |
| Oct 6, 2026 | 1.28 | 1.28 | 1.16 | 1.18 | 77.50K |
| Oct 5, 2026 | 1.39 | 1.40 | 1.00 | 1.27 | 82.30K |
| Oct 2, 2026 | 1.44 | 1.65 | 1.40 | 1.42 | 62.30K |
| Oct 1, 2026 | 1.48 | 1.55 | 1.40 | 1.48 | 48.00K |
| Sep 30, 2026 | 1.60 | 1.63 | 1.43 | 1.62 | 63.40K |
| Sep 29, 2026 | 1.54 | 1.60 | 1.47 | 1.52 | 42.90K |
| Sep 28, 2026 | 1.60 | 1.80 | 1.52 | 1.52 | 44.00K |
| Sep 25, 2026 | 1.57 | 1.68 | 1.44 | 1.65 | 37.60K |
| Sep 24, 2026 | 1.61 | 1.68 | 1.49 | 1.57 | 59.90K |
| Sep 23, 2026 | 1.65 | 1.69 | 1.49 | 1.62 | 35.70K |
| Sep 22, 2026 | 1.69 | 1.69 | 1.50 | 1.65 | 33.40K |
| Sep 21, 2026 | 1.73 | 1.75 | 1.60 | 1.61 | 36.00K |
About Radiopharm Theranostics
Radiopharm Theranostics (RADX) is listed on the Nasdaq and classified by the SEC under “Pharmaceutical Preparations”. Its business address is in CARLTON VIC. State of incorporation: Australia. Fiscal year ends June 30. SEC CIK 1949257.
RADX board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| Riccardo Canevari | Managing Director and CEO | Mar 31, 2026 |
| Noel Donnelly | Director | Apr 1, 2026 |
| Bruce Michael Goodwin | Director | Mar 18, 2026 |
| Paul Hopper | Director | May 6, 2026 |
| Hester Denise Larkin | Director | Mar 31, 2026 |
| Ian Lawrence Turner | Director | Apr 1, 2026 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| Riccardo Canevari | Managing Director and CEO | Mar 31, 2026 |
| Aaron James Laurita | Chief Financial Officer | Apr 30, 2026 |
| Dimitris Voliotis | Chief Medical Officer | May 6, 2026 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| No open-market insider buys or sales reported in the last 12 months. | ||||
RADX financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| No annual XBRL figures available (foreign filers often report on Form 20-F). | ||||
Latest balance sheet: total assets $—, total liabilities $—, cash $—.
RADX earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| No 8-K earnings releases in recent filings. | ||
Related stocks · Pharmaceutical Preparations
Eli Lilly (LLY)Johnson & Johnson (JNJ)Merck (MRK)AbbVie (ABBV)Abbott Laboratories (ABT)Pfizer (PFE)Bristol Myers Squibb (BMY)Vertex Pharmaceuticals Inc / Ma (VRTX)Novo Nordisk A S (NVO)Regeneron Pharmaceuticals (REGN)
Popular today
Spdr S&P 500 Etf (SPY)Micron Technology (MU)Nvidia (NVDA)Meta Platforms (META)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Tesla (TSLA)Apple (AAPL)Intel (INTC)Microsoft (MSFT)Amazon (AMZN)
More on RADX
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 16, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.